Twist Bioscience (TWST) saw its shares surge in the last session with trading volume being higher than average. The latest ...

Leproust, Ph.D., CEO and co-founder of Twist Bioscience. "We constantly look for ways to meet the academic research community in their place of need. By making Express shipping the default option at ...

We recently published a list of 10 Best Immunology Stocks To Buy Now. In this article, we are going to take a look at where ...

Victory Capital Management Inc. boosted its holdings in Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 12.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & ...

Earnings Estimate Revisions for Twist Bioscience For the fiscal year ending September 2025, this maker of synthetic DNA for the biotechnology industry is expected to earn -$2.21 per share, which ...

Twist Bioscience Co. has a twelve month low of $27.41 and a twelve month high of $60.90. The company has a quick ratio of 4.62, a current ratio of 4.96 and a debt-to-equity ratio of 0.03.

Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that its executives will participate ...

TD Cowen analyst Brendan Smith maintained a Buy rating on Twist Bioscience (TWST – Research Report) today and set a price target of $58.00. The ...

Twist Bioscience (TWST) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector ...